RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER
Alfayoumi, T., Fayed, H., Soliman, M., El Damati, A., Heikle, M. (2022). RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER. EKB Journal Management System, 4(2), 14-15. doi: 10.21608/alexpo.2022.138064.1401
Tarek Abdel Halim Alfayoumi; Haytham Mahmoud Fayed; Maher Mohammed Soliman; Ahmed Mahmoud El Damati; Mohamed Saad Heikle. "RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER". EKB Journal Management System, 4, 2, 2022, 14-15. doi: 10.21608/alexpo.2022.138064.1401
Alfayoumi, T., Fayed, H., Soliman, M., El Damati, A., Heikle, M. (2022). 'RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER', EKB Journal Management System, 4(2), pp. 14-15. doi: 10.21608/alexpo.2022.138064.1401
Alfayoumi, T., Fayed, H., Soliman, M., El Damati, A., Heikle, M. RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER. EKB Journal Management System, 2022; 4(2): 14-15. doi: 10.21608/alexpo.2022.138064.1401

RETROSPECTIVE STUDY OF THE IMPACT OF NEOADJUVANT THERAPY ON SURGICAL DECISIONS IN PATIENTS WITH BREAST CANCER

ALEXMED ePosters
Article 2, Volume 4, Issue 2, June 2022, Page 14-15  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.138064.1401
View on SCiNiTO View on SCiNiTO
Authors
Tarek Abdel Halim Alfayoumi1; Haytham Mahmoud Fayed2; Maher Mohammed Soliman3; Ahmed Mahmoud El Damati4; Mohamed Saad Heikle email 2
1Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
2Department of General Surgery, Faculty of Medicine, University of Alexandria
3Department of Clinical Oncology, Faculty of Medicine, University of Alexandria
401552403570
Abstract
Breast cancer is the universal most frequently diagnosed cancer in women. Over time, evolutions in understanding the biological behavior of breast cancer as a disease has made a paradigm shift in its management from radical to more conservative treatment strategies with comparable oncological outcome, overall survival yet with better quality of life, thus, making cancer breast - when early detected - less concerning type of cancer, especially that high rates of cure is being achieved.
A multidisciplinary team approach is needed for ideal management of breast cancer aiming primarily at reduction in breast cancer mortality as well as several cosmetic and oncological advantages. Breast conservation surgery is the standard of care surgical procedure for early breast cancer patients. Neoadjuvant therapy refers to the systemic treatment of breast cancer prior to definitive surgical therapy. While all systemic therapy given for non-metastatic invasive breast cancer intended to reduce risk of distant recurrence, the drive of administering it prior to surgery is to downstage the tumor and to have information regarding treatment response.
Keywords
breast cancer; neoadjuvant therapy; breast conserving surgery
Supplementary Files
Statistics
Article View: 126